Exact Sciences Shares Outstanding 2006-2019 | EXAS

Exact Sciences shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Exact Sciences shares outstanding for the quarter ending September 30, 2019 were 0.130B, a 5.62% increase year-over-year.
  • Exact Sciences 2018 shares outstanding were 0.122B, a 5.64% increase from 2017.
  • Exact Sciences 2017 shares outstanding were 0.116B, a 13.04% increase from 2016.
  • Exact Sciences 2016 shares outstanding were 0.102B, a 11.07% increase from 2015.
Exact Sciences Annual Shares Outstanding
(Millions of Shares)
2018 122
2017 116
2016 102
2015 92
2014 80
2013 67
2012 59
2011 53
2010 40
2009 33
2008 27
2007 27
2006 27
2005 26
Exact Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 130
Q2 2019 129
Q1 2019 126
Q4 2018 122
Q3 2018 123
Q2 2018 122
Q1 2018 121
Q4 2017 116
Q3 2017 119
Q2 2017 113
Q1 2017 111
Q4 2016 102
Q3 2016 105
Q2 2016 98
Q1 2016 97
Q4 2015 92
Q3 2015 94
Q2 2015 89
Q1 2015 89
Q4 2014 80
Q3 2014 83
Q2 2014 82
Q1 2014 71
Q4 2013 67
Q3 2013 71
Q2 2013 65
Q1 2013 64
Q4 2012 59
Q3 2012 61
Q2 2012 57
Q1 2012 57
Q4 2011 53
Q3 2011 52
Q2 2011 52
Q1 2011 52
Q4 2010 40
Q3 2010 40
Q2 2010 39
Q1 2010 36
Q4 2009 33
Q3 2009 35
Q2 2009 31
Q1 2009 30
Q4 2008 27
Q3 2008 27
Q2 2008 27
Q1 2008 27
Q4 2007 27
Q3 2007 27
Q2 2007 27
Q1 2007 27
Q4 2006 27
Q3 2006 27
Q2 2006 26
Q1 2006 26
Q4 2005 26
Q3 2005 26
Q2 2005 26
Q1 2005 26
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.747B $0.876B
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.810B 15.07
CSL (CSLLY) Australia $100.765B 0.00
Gilead Sciences (GILD) United States $85.473B 11.00
Vertex Pharmaceuticals (VRTX) United States $63.215B 57.37
Biogen (BIIB) United States $57.963B 9.90
Regeneron Pharmaceuticals (REGN) United States $43.958B 18.62
Illumina (ILMN) United States $43.941B 45.43
Alexion Pharmaceuticals (ALXN) United States $22.707B 10.56
Seattle Genetics (SGEN) United States $20.339B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.006B 36.49
BioMarin Pharmaceutical (BMRN) United States $15.988B 0.00
Genmab (GNMSF) Denmark $14.741B 65.11
Alnylam Pharmaceuticals (ALNY) United States $14.490B 0.00
Galapagos (GLPG) Belgium $14.198B 36.58
Bio-Rad Laboratories (BIO.B) United States $12.078B 56.43
BeiGene (BGNE) Cayman Islands $10.449B 0.00
Sarepta Therapeutics (SRPT) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.375B 25.79
Bio-Techne Corp (TECH) United States $7.997B 54.73
Guardant Health (GH) United States $7.916B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.099B 0.00
BioNTech SE (BNTX) Germany $6.958B 0.00
Reata Pharmaceuticals (RETA) United States $6.831B 0.00
Ascendis Pharma (ASND) Denmark $6.732B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.730B 17.11
Moderna (MRNA) United States $6.394B 0.00
Exelixis (EXEL) United States $6.311B 17.75
Amarin (AMRN) Ireland $6.294B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.105B 0.00
Repligen (RGEN) United States $5.517B 99.97
Acceleron Pharma (XLRN) United States $4.972B 0.00
Bluebird Bio (BLUE) United States $4.942B 0.00
China Biologic Products (CBPO) China $4.597B 25.89
Adaptive Biotechnologies (ADPT) United States $3.913B 0.00
MorphoSys AG (MOR) Germany $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.635B 0.00
Blueprint Medicines (BPMC) United States $3.619B 0.00
NeoGenomics (NEO) United States $3.569B 189.89
Immunomedics (IMMU) United States $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.532B 0.00
Zai Lab (ZLAB) China $3.517B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.395B 57.53
Emergent Biosolutions (EBS) United States $3.261B 32.40
MyoKardia (MYOK) United States $3.254B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.157B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.104B 0.00
Halozyme Therapeutics (HALO) United States $3.092B 0.00
Genmab (GMAB) Denmark $3.074B 6.33
Alkermes (ALKS) Ireland $2.804B 222.13
Amicus Therapeutics (FOLD) United States $2.798B 0.00
UniQure (QURE) Netherlands $2.756B 0.00
Insmed (INSM) United States $2.737B 0.00
Arena Pharmaceuticals (ARNA) United States $2.706B 6.29
Denali Therapeutics (DNLI) United States $2.441B 0.00
Epizyme (EPZM) United States $2.209B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Fate Therapeutics (FATE) United States $2.183B 0.00
Principia Biopharma (PRNB) United States $2.120B 0.00
Alector (ALEC) United States $2.068B 0.00
REGENXBIO (RGNX) United States $1.980B 0.00
Zymeworks (ZYME) Canada $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.708B 49.86
Arvinas (ARVN) United States $1.698B 0.00
Akcea Therapeutics (AKCA) United States $1.686B 0.00
Zealand Pharma (ZEAL) Denmark $1.595B 0.00
Coherus BioSciences (CHRS) United States $1.525B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.456B 0.00
Myriad Genetics (MYGN) United States $1.448B 25.55
Editas Medicine (EDIT) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Intra-Cellular Therapies (ITCI) United States $1.266B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Athenex (ATNX) United States $1.206B 0.00
PHARMA MAR SA (PHMMF) Spain $1.184B 0.00
Revance Therapeutics (RVNC) United States $1.143B 0.00
Twist Bioscience (TWST) United States $1.070B 0.00
Adverum Biotechnologies (ADVM) United States $1.020B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Mesoblast (MESO) Australia $0.948B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.878B 0.00
Cytokineticsorporated (CYTK) United States $0.877B 0.00
DBV Technologies S.A (DBVT) France $0.861B 0.00
Vericel (VCEL) United States $0.852B 317.83
Codexis (CDXS) United States $0.821B 0.00
Heska (HSKA) United States $0.807B 206.14
ANI Pharmaceuticals (ANIP) United States $0.794B 13.54
Cellectis S.A (CLLS) France $0.742B 0.00
Retrophin (RTRX) United States $0.712B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
Intrexon (PGEN) United States $0.695B 0.00
GENFIT S.A (GNFT) France $0.694B 0.00
Intellia Therapeutics (NTLA) United States $0.678B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 5.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
NantKwest (NK) United States $0.620B 0.00
Anika Therapeutics (ANIK) United States $0.592B 19.20
UROGEN PHARMA (URGN) United States $0.586B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.576B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.31
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.538B 0.00
Prothena (PRTA) Ireland $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Arcus Biosciences (RCUS) United States $0.506B 0.00
Agenus (AGEN) United States $0.503B 0.00
Bellus Health (BLU) Canada $0.493B 0.00
Puma Biotechnology (PBYI) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
Compugen (CGEN) Israel $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Sorrento Therapeutics (SRNE) United States $0.456B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.449B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.437B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Inovio Pharmaceuticals (INO) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.419B 10.49
AnaptysBio (ANAB) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.399B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.373B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.339B 0.00
Syros Pharmaceuticals (SYRS) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Albireo Pharma (ALBO) United States $0.314B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.308B 2.13
AMAG Pharmaceuticals (AMAG) United States $0.302B 0.00
MannKind (MNKD) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.290B 0.00
Kamada (KMDA) Israel $0.290B 12.06
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
IVERIC Bio (ISEE) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
OSMOTICA PHARM (OSMT) United States $0.264B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.264B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.260B 0.00
Geron (GERN) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
Novavax (NVAX) United States $0.247B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
ChromaDex (CDXC) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.239B 0.00
XOMA (XOMA) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.222B 0.00
Prometic Life Sciences (LMNL) Canada $0.221B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
Alcobra (ARCT) United States $0.210B 0.00
Fortress Biotech (FBIO) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.205B 0.00
Exicure (XCUR) United States $0.205B 0.00
Cerecor (CERC) United States $0.201B 0.00
Athersys (ATHX) United States $0.194B 0.00
Affimed (AFMD) Germany $0.193B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.192B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Strongbridge Biopharma (SBBP) United States $0.178B 4.77
Spero Therapeutics (SPRO) United States $0.172B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Five Prime Therapeutics (FPRX) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Selecta Biosciences (SELB) United States $0.157B 0.00
Dyadic (DYAI) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
Verastem (VSTM) United States $0.149B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.137B 0.00
ARAVIVE, INC (ARAV) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.119B 0.00
Arsanis (XFOR) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.115B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
OvaScience (MLND) United States $0.107B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Applied Genetic Technologies (AGTC) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Acorda Therapeutics (ACOR) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 5.08
Synlogic (SYBX) United States $0.078B 0.00
Trevena (TRVN) United States $0.072B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
NewLink Genetics (NLNK) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00